HTFLHeartflow, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $176M
- 40% YoY
- Operating margin
- -36.4%
- 25% YoY
- EBITDA
- −$59M
- 4.9% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear8% of revenueOver 10% of revenue
- Payouts exceed cash flowClear-0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $87M | $126M | $176M | 40% |
| Operating income | −$73M | −$61M | −$64M | 4.6% |
| Net income | −$96M | −$96M | −$117M | 21% |
| Operating cash flow | −$76M | −$69M | −$54M | 22% |
| Capex | $6M | $4M | $5M | 15% |
| Stock-based comp | $12M | $10M | $14M | 37% |
| Buybacks | $228K | — | — |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $11M · 14
- Net
- −$11M
Pay vs performance
No pay-versus-performance disclosure yet.